Andrea Tan
Stock Analyst at Goldman Sachs
(0.79)
# 3,763
Out of 4,843 analysts
45
Total ratings
31.43%
Success rate
-16.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $1.75 | +357.14% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $42.95 | +18.74% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.38 | +323.20% | 6 | Mar 25, 2025 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $69.73 | +46.28% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $3.55 | +69.01% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $16.07 | +92.91% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.75 | +166.67% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $3.41 | -41.35% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $126.17 | +26.81% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $2.02 | +1,088.12% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.21 | +230.58% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $275.26 | +36.23% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $4.45 | +192.13% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.20 | +1,901.00% | 2 | May 24, 2022 |
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $1.75
Upside: +357.14%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $42.95
Upside: +18.74%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.38
Upside: +323.20%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $69.73
Upside: +46.28%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $3.55
Upside: +69.01%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $16.07
Upside: +92.91%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.75
Upside: +166.67%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $3.41
Upside: -41.35%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $126.17
Upside: +26.81%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $2.02
Upside: +1,088.12%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.21
Upside: +230.58%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $275.26
Upside: +36.23%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $4.45
Upside: +192.13%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.20
Upside: +1,901.00%